Cramer's lightning round: Buy Vertex Pharmaceuticals

Source
Stock Chart Icon Stock chart icon
hide content
Vertex Pharmaceutical's year-to-date stock performance.

Vertex Pharmaceuticals: "I think Vertex is very strong. I wish I had bought it for the Charitable Trust a long time ago when we had the CEO on. It was an excellent call, and then I got cold feet. That was a mistake. It's a good buy."

Stock Chart Icon Stock chart icon
hide content
Oddity Tech's year-to-date stock performance.

Oddity Tech: "Frankly, that industry...is just too hard. And that was my bad that I just didn't realize how hard when we had them on the show. I thought they told a very good story, but the story did not pan out."

Stock Chart Icon Stock chart icon
hide content
ImmunityBio's year-to-date stock performance.

ImmunityBio: "I'm going to tell you that it is not clear exactly what they did wrong, but they got in trouble. I got to see how they get out of trouble, and then we'll take a hard look at it."

Stock Chart Icon Stock chart icon
hide content
Aehr Test Systems' year-to-date stock performance.

Aehr Test Systems: "The stock has run too much. It went parabolic. We have to wait. I wish I didn't have to say it, but we have to wait."

Stock Chart Icon Stock chart icon
hide content
Copart's year-to-date stock performance.

Copart: "I want to buy that stock. It's too cheap...I think you're buying it right at the bottom."

Jim Cramer's Guide to Investing

Click here to download Jim Cramer's Guide to Investing at no cost to help you build long-term wealth and invest smarter.

Sign up now for the CNBC Investing Club to follow Jim Cramer's every move in the market.

Disclaimer

Questions for Cramer?
Call Cramer: 1-800-743-CNBC

Want to take a deep dive into Cramer's world? Hit him up!
Mad Money Twitter - Jim Cramer Twitter - Facebook - Instagram

Questions, comments, suggestions for the "Mad Money" website? madcap@cnbc.com

Choose CNBC as your preferred source on Google and never miss a moment from the most trusted name in business news.